Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic responses to epinephrine during inferior alveolar vs Gow-Gates mandibular anesthesia
IRCT20241004063259N1Phase 2Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of epinephrine in hemodynamic response abnormality (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoint: Hemodynamic responses to epinephrine. Started Oct 2024; status: completed.
02
Drugs
epinephrine
03
Conditions
hemodynamic response abnormality
Beyond the preview
Go deeper on IRCT20241004063259N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241004063259N1.